Filing Details

Accession Number:
0001209191-19-019307
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-13 20:45:26
Reporting Period:
2019-03-12
Accepted Time:
2019-03-13 20:45:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1605456 K Vivek Jayaraman C/O Cerus Corporation
2550 Stanwell Drive
Concord CA 94520
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-12 3,750 $0.00 65,308 No 4 M Direct
Common Stock Acquisiton 2019-03-12 15,834 $0.00 81,142 No 4 M Direct
Common Stock Disposition 2019-03-13 5,979 $5.90 75,163 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2019-03-12 3,750 $0.00 3,750 $0.00
Common Stock Restricted Stock Unit Disposition 2019-03-12 15,834 $0.00 15,834 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,750 No 4 M Direct
31,666 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
  2. Includes 4,823 and 1,951 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/18 and 02/28/19, respectively.
  3. Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.
  4. The restricted stock unit vests in three equal annual installments beginning on March 12, 2018.
  5. Not applicable.
  6. The restricted stock unit vests in three equal annual installments beginning on March 12, 2019.